Authors
Loading...
Machine learning uncovers new SNPs and therapeutic targets for rare diseases, suggesting effective analysis methods.
Aguerd et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: